ESSA PHARMA INC (EPIX)       3.75  +0.06 (+1.63%)

3.75  +0.06 (+1.63%)

CA29668H7085 - Common Stock

News Image
22 days ago - ESSA Pharma Inc

ESSA Pharma to Participate in Two Upcoming Investor Conferences

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
25 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Good morning, investor! We're diving into the biggest pre-market stock movers for Monday as we get ready for another week of trading!

News Image
a month ago - ESSA Pharma Inc

ESSA Provides an Update on its Clinical Collaboration with Janssen

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
a month ago - ESSA Pharma Inc

ESSA Provides an Update on its Clinical Collaboration with Janssen

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another dive into the biggest pre-market stock movers as we check out the latest stock news for Thursday morning!

News Image
a month ago - ESSA Pharma Inc

ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
a month ago - InvestorPlace

Mullen (MULN) Stock Heats Up on Expanded Promotional Tour

Mullen (MULN) stock is moving on Wednesday as investors prepare for the electric vehicle (EV) company's expanded promotional tour.

News Image
a month ago - ESSA Pharma Inc

Updated Results from the Phase 1/2 Study of ESSA's Lead Candidate EPI-7386 in Combination with Enzalutamide Highlighted at the 29th Annual Prostate Cancer Foundation Scientific Retreat

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
3 months ago - ESSA Pharma Inc

ESSA Pharma Appoints Philip Kantoff to its Board of Directors

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
3 months ago - ESSA Pharma Inc

ESSA Pharma Appoints Philip Kantoff to its Board of Directors

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for...

News Image
4 months ago - BusinessInsider

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2022

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Aug. 4, 2022 /PRNewswire/ - ESSA Pharma Inc. ('ESSA', or the 'Company') (NASDAQ: EPIX), a c...

News Image
4 months ago - ESSA Pharma Inc

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2022

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
5 months ago - ESSA Pharma Inc

ESSA Pharma Insiders Establish Automatic Securities Disposition Plans

/CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
5 months ago - ESSA Pharma Inc

ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

News Image
5 months ago - ESSA Pharma Inc

ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for...

News Image
6 months ago - BusinessInsider

ESSA Pharma to Present at 2022 Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, June 2, 2022 /PRNewswire/ - ESSA Pharma Inc. ('ESSA', or the 'Company') (NASDAQ: EPIX), a c...

News Image
6 months ago - ESSA Pharma Inc

ESSA Pharma to Present at 2022 Jefferies Healthcare Conference

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...